Although ISG expression was higher in patients with known type I interferonopathies, patients with mutations in the gene RNASEH2B were more likely to have negative interferon signatures. Of the 8 patients with negative IS, seven had mutations in this particular gene. Additionally, the median interferon score in 26 patients positive for RNASEH2B mutations were lower than all of the other affected genes combined.